Page 1

9/19/24 , 2:41 PM Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights | Achilles Therapeutics ... ACHILLES THERAPEUTICS PRESS RELEASE Achilles Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights Aug 10 2021 - Presentations of translational science data at AACR and ASCO illustrate crucial path to potency assay- - Data from ten patients across CHIRON and THETIS studies anticipated in the fourth quarter of 2021 - LONDON , Aug. 10 , 2021 ( GLOBE NEWSWIRE ) -- Achilles Therapeutics plc ( NASDAQ : ACHL ) , a clinical - stage biopharmaceutical company developing precision T cell therapies to treat solid tumors , today announced its financial results for the second quarter ended June 30 , 2021 , and recent business highlights . " Achilles continued to make significant progress in the second quarter of 2021. We presented data at AACR and ASCO demonstrating that we can quantify the active clonal neoantigen - reactive T cell ( cNeT ) component and cNeT dose of our product . We were also able to track our cNeT post- https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-reports-second-quarter-2021-financial 1/7